DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2014 Update

Date: May 14, 2014
Pages: 30
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D104D1C5CB7EN
Leaflet:

Download PDF Leaflet

DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2014 Update
Summary

DexCom, Inc. (DexCom) is a medical device company. It undertakes the design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. Its major products include DexCom G4 Platinum, DexCom G4 Platinum (Pediatric) and DexCom Seven Plus continuous glucose monitoring systems. The company’s in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also offers DexCom Studio software to download reports; and DexCom mobile application on iOS and Android platform. The company also offers data transfer services through its subsidiary SweetSpot Diabetes Care, Inc. DexCom is headquartered in San Diego, California, the US.

DexCom seeks to become a leading provider of continuous glucose monitoring systems and related products through the development of innovative products and enhancement of existing products, internal development, strong partner relationships and strategic alliances.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company DexCom, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
DexCom, Inc. Company Snapshot
DexCom, Inc. Company Overview
Key Information
DexCom, Inc. Pipeline Products and Clinical Trials Overview
DexCom, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
DexCom, Inc. - Major Products and Services
DexCom, Inc. Pipeline Products by Development Stage
DexCom, Inc. Pipeline Products Overview
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR
5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR PRODUCT OVERVIEW
Dexcom G4 PLATINUM Continuous Glucose Monitor - Pediatric Indication
Dexcom G4 PLATINUM Continuous Glucose Monitor - Pediatric Indication Product Overview
DexCom Share System
DexCom Share System Product Overview
G4 Platinum – Advanced Algorithm
G4 Platinum – Advanced Algorithm Product Overview
GlucoClear
GlucoClear Product Overview
GlucoClear - Second Generation
GlucoClear - Second Generation Product Overview
SEVEN PLUS System - Pediatrics
SEVEN PLUS System - Pediatrics Product Overview
SEVEN PLUS System - Pregnancy
SEVEN PLUS System - Pregnancy Product Overview
DexCom, Inc. - Key Competitors
DexCom, Inc. - Key Employees
DexCom, Inc. - Key Employee Biographies
DexCom, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
DexCom, Inc., Recent Developments
May 01, 2014: DexCom Reports First Quarter 2014 Financial Results
Mar 25, 2014: DexCom Receives FDA Warning Letter for Administrative Deficiencies in its MDR Reporting
Mar 05, 2014: Dexcom Supports NASCAR Driver Ryan Reed’s American Diabetes Association Drive to Stop Diabetes Initiative
Feb 20, 2014: DexCom Reports Fourth Quarter and Full Year 2013 Financial Results
Feb 03, 2014: Innovative Dexcom G4 PLATINUM Continuous Glucose Monitor Receives FDA Approval for Use in Children Ages 2 to 17 Years
Jan 13, 2014: Dexcom’s Innovative Diabetes Monitoring Device Recognized For Outstanding Achievement at Consumer Electronics Show
Jan 07, 2014: DexCom to Present at J.P. Morgan 2014 Healthcare Conference
Nov 21, 2013: DexCom Announces Upcoming Conference Presentations
Nov 06, 2013: DexCom Announces Appointment of Steve Altman as Board Member
Nov 06, 2013: DexCom Reports Third Quarter 2013 Financial Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

DexCom, Inc., Key Facts
DexCom, Inc. Pipeline Products and Clinical Trials Overview
DexCom, Inc. Pipeline Products by Equipment Type
DexCom, Inc. Pipeline Products by Indication
DexCom, Inc., Key Facts
DexCom, Inc., Major Products and Services
DexCom, Inc. Number of Pipeline Products by Development Stage
DexCom, Inc. Pipeline Products Summary by Development Stage

5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PRODUCT STATUS


5TH GENERATION CONTINUOUS GLUCOSE MONITORING (CGM) SENSOR - PRODUCT DESCRIPTION

Dexcom G4 PLATINUM Continuous Glucose Monitor - Pediatric Indication - Product Status
Dexcom G4 PLATINUM Continuous Glucose Monitor - Pediatric Indication - Product Description
DexCom Share System - Product Status
DexCom Share System - Product Description
G4 Platinum – Advanced Algorithm - Product Status
G4 Platinum – Advanced Algorithm - Product Description
GlucoClear - Product Status
GlucoClear - Product Description
GlucoClear - Second Generation - Product Status
GlucoClear - Second Generation - Product Description
SEVEN PLUS System - Pediatrics - Product Status
SEVEN PLUS System - Pediatrics - Product Description
SEVEN PLUS System - Pregnancy - Product Status
SEVEN PLUS System - Pregnancy - Product Description
DexCom, Inc., Key Employees
DexCom, Inc., Key Employee Biographies
DexCom, Inc., Subsidiaries

LIST OF FIGURES

DexCom, Inc. Pipeline Products by Equipment Type
DexCom, Inc. Pipeline Products by Development Stage

Ask Your Question

DexCom, Inc. (DXCM) - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: